p75 Neurotrophin receptor induction and macrophage infiltration in peripheral nerve during experimental diabetic neuropathy: Possible relevance on regeneration

Experimental Neurology

Volumn 146, Issue 1, 1997, Pages 206-211

  Conti, Giancarlo ^a   Stoll, Guido ^b   Scarpini, Elio ^a   Baron, Pier Luigi ^a   Bianchi, Roberto ^c   Livraghi, Simona ^a   Scarlato, Guglielmo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTROPHIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; MACROPHAGE; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031193431     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6521     Document Type: Article

References (43)

1. 1. Anton, E. S., G. Weskamp, L. F. Reichard, and W. D. Matthew. 1994. Nerve growth factor and its low-affinity receptor promote Schwann cell migration. Proc. Natl. Acad. Sci. USA 91: 2795-2799.
2. 2. Apfel, S. C., J. C. Arezzo, M. Brownelee, H. Federoff, and J. Kessler. 1994. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain. Res. 634: 7-12.
3. 3. Bergsteindottir, K., A. Kingston, R. Mirsky, and K. R. Jessen. 1991. Rat Schwann cells produce interleukin-1. J. Neuroimmunol. 34: 15-23.
4. 4. Beuche, W., and R. L. Friede. 1984. The role of non-resident cells in Wallerian degeneration. J. Neurocytol. 13: 767-796.
5. 5. Brown, M. J., and A. K. Asbury. 1984. Diabetic neuropathy. Ann. Neurol. 15: 2-12.
6. 6. Brown, M. J., V. H. Perry, E. R. Lunn, S. Gordon, and R. Heumann. 1991. Macrophage dependence of peripheral sensory nerve regeneration: Possible involvement of nerve growth factor. Neuron 6: 359-370.
7. 7. Calcutt, N. A., H. F. McMurray, D. F. Moorhouse, M. Bache, S. Parthasarathy, H. Powell, and A. Mizisin. 1994. Inhibition of macrophage chemotaxis and peripheral nerve regeneration in normal and hyperglycemic rats by the aldose reductase inhibitor tolrestat. Exp. Neurol. 128: 226-232.
8. 8. Carter, B. D., C. Kaltschmidt, B. Kaltschmidt, N. Offenhauser, R. Bohm-Matthael, P. Baeurle, and Y. Barde. 1996. Selective activation of NF-κB by Nerve Growth Factor through the neurotrophin receptor p75.Science 272: 542-545.
9. 9. Chao, M. V., and B. L. Hempstead. 1995. p75 and TRK: A two-receptor system. Trends Neurosci. 18: 321-326.
10. 10. Conti, G., C. A. Vedeler, P. Bannerman, A. Rostami, and D. Pleasure. 1992. Peripheral nervous system (PNS) expression of mRNAs encoding myelin proteins and FcyRIII during experimental allergic neuritis. J. Neuroimmunol. 41: 43-50.
11. 11. Conti, G., P. L. Baron, E. Scarpini, C. A. Vedeler, A. Rostami, D. Pleasure, and G. Scarlato. 1995. Low-affinity nerve growth factor receptor expression in sciatic nerve during P2-peptide induced experimental allergic neuritis. Neurosci. Lett. 199: 135-138.
12. 12. Dechant, G., A. Rodriguez-Tebar, A. Barde. 1994. Neurotrophin receptors. Prog. Neurobiol. 42: 347-352.
13. 13. Goodrum, J. F., and D. L. Novicki. 1986. Macrophages-like cells from explant cultures of rat sciatic nerve produce apolipoprotein. Eur. J. Neurosci. Res. 20: 457-462.
14. 14. Griffin, J. W., R. George, and T. Ho. 1993. Macrophage systems in peripheral nerves. A review. J. Neuropathol. Exp. Neurol. 52: 553-560.
15. 15. Hartung, H. P., and K. V. Toyka. 1990. T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barré syndrome. Ann. Neurol. 27: S57-S63.
16. 16. Hellweg, R., and H. D. Hartung. 1990. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy. J. Neurosci. Res. 26: 258-267.
17. 17. Hellweg, R., M. Wohrl, H. D. Hartung, H. Stracke, C. Hook, and K. Fedelin. 1991. Diabetes mellitus associated decrease in nerve growth factor levels is reversed by allogenic pancreatic islet transplantation. Neurosci. Lett. 125: 1-4.
18. 18. Helleweg, R., G. Raivich, H. D. Hartung, C. Hock, and G. W. Kreutzberg. 1994. Axonal transport of endogenous NGF and NGF receptor in experimental diabetic neuropathy. Exp. Neurol. 130: 24-30.
19. 19. Heuman, R., D. Lindholm, C. Bandtlow, M. Mayer, M. Radeke, T. Misko, E. Shooter, and H. Thonen. 1987. Differential regulation of mRNA encoding nerve growth factor and its receptor in rat sciatic nerve during development, degeneration, and regeneration: Role of macrophages. Proc. Natl. Acad. Sci. USA 84: 8735-8739.
20. 20. Jakobsen, J., S. Brimijoin, K. Skau, P. Sidenius, and D. Wells. 1981. Retrograde axonal transport of transmitter enzymes, fucose-labeled protein and nerve growth factor in streptozocin-diabetic rats. Diabetes 30: 797-803.
21. 21. Kasayama, S., and T. Oka. 1989. Impaired production of nerve growth factor in the submandibular gland of diabetic mice. Am. J. Physiol. 257: E400-E404.
22. 22. Lindholm, D., R. Heuman, M. Meyer, and T. Thoenen. 1987. Interleukin-1 regulates synthesis of nerve growth factor in non neural cells of rat sciatic nerve. Nature 330: 658-659.
23. 23. Lindholm, D., R. Heuman, B. Hengere, and T. Thoenen. 1988. Interlukin-1 increases stability and transcription of mRNA encoding nerve growth factor in cultured fibroblast. J. Biol. Chem. 263: 16348-16351.
24. 24. Lisak, R. P., and B. Bealmear. 1991. Antibodies to interleukin-1 inhibit cytokine-induced proliferation of neonatal rat Schwann cell in vivo. J. Neuroimmunol. 31: 123-132.
25. 25. Lunn, E. R., V. H. Perry, M. C. Brown, C. Rosen, and S. Gordon. 1989. Absence of wallerian degeneration does not hinder regeneration in peripheral nerve. Eur. J. Neurosci. 1: 27-33.
26. 26. Mokuno, K., G. Sobue, U. R. Reddy, J. Wurzer, B. Kreider, H. Hotta, P. Baron, A. H. Ross, and D. Pleasure. 1988. Regulation of Schwann cell nerve growth factor receptor by cyclic adenosine 3′,5′-monophosphate. J. Neurosci. Res. 21: 465-472.
27. 27. Perry, W. H., M. C. Brown, and S. Gordon. 1987. The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration. J. Exp. Med. 165: 1218-1223.
28. 28. Raivich, G., and G. W. Kreutzberg. 1987. Expression of growth factor receptors in injured nervous tissue. Axotomy leads to a shift in cellular distribution of specific B-nerve growth factor binding in the injured and regenerating PNS. J. Neurocytol. 16: 689-700.
29. 29. Rodriguez-Tebar, A., G. Dechanl, and A. Barde. 1990. Binding of brain-derived neurotrophic factor to the nerve growth factor receptor. Neuron 4: 487-492.
30. 30. Said, G., and M. Hontebeyrie-Joskowicz. 1992. Nerve lesions induced by macrophage activation. Res. Immunol. 143: 589-599.
31. 31. Said, G., C. Goulon-Goeau, C. Lacroix, and A. Molounget. 1994. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann. Neurol. 35: 559-569.
32. 32. Scarpini, E., S. Beretta, A. H. Ross, M. Moggio, S. Jann, D. Pleasure, and G. Scarlato. 1989. Rapid quantitative immunohistochemical assessment of human peripheral neuropathies using a monoclonal antibody against nerve growth factor receptor. J. Neurol. 236: 439-444.
33. 33. Scarpini, E., G. Conti, L. Chianese, P. L. Baron, S. Pizzul, A. Basellini, S. Livraghi, and G. Scarlato. 1996. Induction of p75NGFR in human diabetic neuropathy. J. Neurol. Sci. 135: 55-62.
34. 34. Sima, A. A. F., M. Bouchier, and H. Christiansen. 1983. Axonal atrophy in sensory nerves of the diabetic BB-Wistar rat: A possible early correlate of human diabetic neuropathy. Ann. Neurol. 13: 264-272.
35. 35. Sima, A. A. F., S. A. Lattimer, S. Yagihashi, and D. A. Greene. 1986. Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic Bio-Breeding rat. J. Clin. Invest. 77: 474-484.
36. 36. Sobue, G., T. Yasuda, T. Mitsuma, A. H. Ross, and D. Pleasure. 1988. Expression of nerve growth factor receptor in human peripheral neuropathies. Ann. Neurol. 24: 6-72.
37. 37. Stoll, G., J. Griffin, C. Yan Li, B. Trapp. 1989. Wallerian degeneration in the peripheral nervous system: Participation of both Schwann cells and macrophages in myelin degradation. J. Neurocytol. 18: 671-683.
38. 38. Stoll, G., C. Yan Li, B. Trapp, and J. Griffin. 1993. Expression of NGF-receptors during immune-mediated and lysolecithin-induced demyelination of the peripheral nervous system. J. Neurocytol. 22: 1022-1029.
39. 39. Tamura, E., and G. Parry. 1994. Severe radicular pathology in rats with longstanding diabetes. J. Neurol. Sci. 127: 29-35.
40. 40. Taniuchi, M., B. H. Clark, J. B. Schweitzer, and E. M. Johnson. 1988. Expression of nerve growth factor receptors by Schwann cells of axotomized peripheral nerves/ultrastructural location, suppression by axonal contact, and binding properties. J. Neurosci. 8: 664-681.
41. 41. Thomas, P. K. 1992. Diabetic neuropathy: Models, mechanisms and mayhem. Can. J. Neurol. Sci. 19: 1-7.
42. 42. Toews, A. D., I. R. Griffiths, E. Kyriadikes, J. F. Goodrum, C. E. Eckermann, P. Morell, and C. E. Thomson. 1992. Primary demyelination induced by exposure to tellurium alters Schwann cell gene expression: A model for intracellular targeting of NGF receptor. J. Neurosci. 12: 3676-3687.
43. 43. Verma, A., and W. B. Bradley. 1994. High dose intravenous immunoglobulin therapy in chronic progressive lumbosacral plexopathy. Neurology 44: 248-250.